Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
Members of Congress who traded GNPX
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 4
- Filings
- 4
- Members
- 1
- Buys / sells
- 4 / 0
- Estimated volume
- $56.5K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Tim MooreRepublican · House · NC | 4 | 4 / 0 | $56.5K | Feb 5, 2026 | Feb 20, 2026 |
Trades
Every reported trade in Genprex, Inc., newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| Tim MooreRepublican · House · NC | GNPXGenprex, Inc. - Common Stock | Buy | Self | Feb 5, 2026 | Feb 20, 2026 | 15 days | $1K-$15K | Filing |
| Tim MooreRepublican · House · NC | GNPXGenprex, Inc. - Common Stock | Buy | Self | Dec 18, 2025 | Jan 7, 2026 | 20 days | $1K-$15K | Filing |
| Tim MooreRepublican · House · NC | GNPXGenprex, Inc. - Common Stock | Buy | Self | Nov 7, 2025 | Dec 2, 2025 | 25 days | $1K-$15K | Filing |
| Tim MooreRepublican · House · NC | GNPXGenprex, Inc. - Common Stock | Buy | Self | Oct 29, 2025 | Nov 12, 2025 | 14 days | $15K-$50K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.